Sign in

CIK 0001119774 · Accelerated filer

COMPUGEN LTD

Sign in to watch
Ticker
CGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
other
Phone
011-972-3-765-8585
Business address
26 HAROKMIM STREET, BUILDING D, HOLON, Israel, 5885849
  1. 4 Grant or award SVP, Business Development acquired 18,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 19,500 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 7,500 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award SVP, Research & Discovery acquired 18,000 shares (grant or award)
  8. 4 Grant or award Director acquired 7,500 shares (grant or award)
  9. 4 Grant or award Director acquired 7,500 shares (grant or award)
  10. 4 Grant or award Director acquired 7,500 shares (grant or award)
  11. 4 Grant or award Director acquired 7,500 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 13,500 shares (grant or award)
  13. 4 Planned sale SVP, Business Development sold 1,875 shares at $2.50 ($4,688)
  14. 4 Planned sale SVP, Business Development sold 2,000 shares at $3.20 ($6,400)
  15. 4 Planned sale President and CEO sold 5,000 shares at $3.20 ($16,001)
  16. 4 Planned sale President and CEO sold 5,000 shares at $2.90 ($14,521)
  17. 4 Planned sale SVP, Business Development sold 2,000 shares at $2.80 ($5,600)
  18. 4/A Planned sale SVP, Business Development sold 3,125 shares at $2.56 ($8,013)
  19. 4 Planned sale SVP, Business Development sold 3,125 shares at $2.56 ($8,013)
  20. 4 Planned sale SVP, Business Development sold 7,875 shares at an average $2.38 ($18,758)

Page 1 of 2 · 36 filings